A detailed history of Ubs Oconnor LLC transactions in Dexcom Inc stock. As of the latest transaction made, Ubs Oconnor LLC holds 24,357 shares of DXCM stock, worth $2.12 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
24,357
Holding current value
$2.12 Million
% of portfolio
0.11%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$64.0 - $116.06 $598,848 - $1.09 Million
9,357 Added 62.38%
24,357 $1.63 Million
Q2 2024

Aug 14, 2024

BUY
$110.31 - $140.45 $1.65 Million - $2.11 Million
15,000 New
15,000 $1.7 Million
Q4 2023

Feb 14, 2024

SELL
$75.49 - $124.16 $1.42 Million - $2.34 Million
-18,828 Reduced 75.31%
6,172 $765,000
Q3 2023

Nov 14, 2023

BUY
$86.06 - $137.93 $2.15 Million - $3.45 Million
25,000 New
25,000 $2.33 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $33.6B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Ubs Oconnor LLC Portfolio

Follow Ubs Oconnor LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Oconnor LLC with notifications on news.